Condition
Valgus Deformity
Total Trials
8
Recruiting
1
Active
3
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
12.5%
1 terminated out of 8 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Active Not Recruiting2
Completed2
Unknown1
Terminated1
Enrolling By Invitation1
Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Showing 8 of 8 trials
NCT05630053Not ApplicableActive Not Recruiting
Cemented vs Cementless Persona Keel RCT
NCT07286513Enrolling By Invitation
Persona SoluTion PPS Femur PMCF
NCT05787821Recruiting
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
NCT04817969Not ApplicableActive Not Recruiting
Persona Ti-Nidium Post-Market Clinical Follow-up
NCT06735586Not ApplicableCompleted
The Effect of Hip Strengthening Exercises and Taping in Patients With PFP With Dynamic Valgus
NCT03664791Unknown
Vanguard Rocc Post Market Surveillance
NCT02088372Terminated
Prospective Multi-Center Study on Vanguard With E1 Bearing
NCT02362867Not ApplicableCompleted
Balanced Knee System Clinical Protocol for IRB Approval
Showing all 8 trials